Discover the exclusive special events at Cord Blood Connect 2024, designed to enhance the professional development of our attendees. Click below to quickly navigate to the specified section and learn more:
Meet the Experts – NEW This Year!
Meet the Experts sessions are an opportunity for attendees to participate in round-table conversations with experts in the Cord Blood field. Each session will be focused on a specific area of interest. Attendance is limited. Be sure to sign up when you register!
Cord Blood Transplants 101 (Session 1)
Friday, September 6 | 12:30 pm – 1:15 pm EDT
Meet CBT physicians doing CBT for malignant and nonmalignant diseases and learn about donor prioritization, outcomes, and treatment guidelines.
- Julie Barker, MD, Attending Physician, Weill Cornell Medicine
- Caridad Martinez, MD, Chief, Pediatric Stem Cell Transplant and Cellular Therapies, Texas Children's Hospital
Cord Blood as a Starting Material for Product Development from the Developers Perspective (Session 2A)
Saturday, September 7 | 7:30 am – 8:15 am EDT
Discuss with experts the opportunities and challenges of cord blood as a starting material for product development from the developer's perspective.
- Amanda Conerty, Executive Director, Process, Analytical Development and Manufacturing, Artiva
- Colleen Delaney, MD, Founder and Chief Scientific Officer, Deverra Therapeutics
International Perspective on Cord Blood and Birthing Tissue Banking and Clinical Applications (Session 2B)
Saturday, September 7 | 7:30 am – 8:15 am EDT
Meet with international experts to discuss cord blood and birthing tissue banking and clinical applications.
- Ngaire Elwood, PhD, Director of BMDI Cord Blood Bank
- Tomasz Baran, MD, CEO FamiCord
Regulatory (Session 3)
Saturday, September 7 | 12:30 pm – 1:15 pm EDT
This is your opportunity to meet and talk with Dr. Peter Marks the director of the Center for Biologics Evaluation and Research at the Food and Drug Administration.
- Peter Marks, MD PhD, Director of Center for Biologics Evaluation and Research, FDA
Private/Family and Public Cord Blood Banking (Session 4)
Sunday, September 8 | 7:30 am – 8:15 am EDT
Talk to the experts about cord blood/birthing tissue banking, sustainability, and future plans for investigative use of cord blood and birthing tissue.
- Peter Bawin, Vice President of Global Marketing, CooperSurgical
- Ana Valverde Vidal, Administrative Director, Marcus Center for Cellular Cures
Welcome Reception
Friday, September 6 | 6:00 pm – 7:00 pm EDT
When the Friday sessions conclude, join us for the Welcome Reception where you can mix and mingle with other Cord Blood Connect attendees! This is the time to connect with old friends and meet some new friends. Complimentary beverages and appetizers will be served.
President's Session
Regulatory and Ethical Aspects of Cord Blood and Birthing Tissues as Starting Materials for Manufacture of Cellular and Regenerative Therapies
Saturday, September 7 | 8:30 am – 10:30 am EDT
Join us for the annual CBA President’s Session where Dr. Joanne Kurtzberg will host presentations and discussion with Jeremy Sugarman, MD, Harvey M. Meyerhoff Professor of Bioethics & Medicine, Johns Hopkins University, and Peter Marks, MD PhD, Director of the Center for Biologics Evaluation and Research, FDA.
The session will cover the emerging uses for cord blood and related birthing tissues in the manufacture of immune effector cells and regenerative therapies. Some of these products are immortalized and others are commercialized. Questions about the ethical requirements for informed consent, access to materials banked decades ago, information about commercialization, and the regulatory standards for use as starting material for manufacturing will be addressed.
Author's Poster Session
Meet the Authors Poster Session and Reception
Saturday, September 7 | 5:30 pm – 6:30 pm EDT
Join us on Saturday afternoon for the Author’s Poster Session and Reception where you will learn about the latest science in the Cord Blood field including:
Poster authors will share their research and answer questions.
|
